High-Resolution Measurement in Cardiovascular Research

Cardiovascular disease remains a leading cause of death worldwide. Yet many trial endpoints still rely on episodic clinic assessments. As a result, they miss how treatment actually affects patients in daily life.

Koneksa’s cardiovascular measurement models close that gap. They integrate digital physiology, functional capacity, patient-reported data, and biomarkers, and then translate continuous signal into clinically interpretable, trial-ready endpoints across both clinic and real-world settings.

Why Real-World Function Matters in Cardiac Trials

Cardiac endpoints have a translation problem. For example, a 6MWT or CPET tells you what a patient can do in a supervised test. However, it says little about what they actually do at home over months of treatment. Continuous capture closes that distance. Gait speed, activity patterns, heart rate dynamics, and ambulatory physiology show function as patients live it, and concept equivalence modeling keeps those real-world signals interpretable against their clinic-based counterparts. Meanwhile, integrating biomarkers like NT-proBNP and imaging-derived progression markers anchors the functional picture to disease biology. This matters most where cardiovascular and metabolic disease interact. In heart failure, CKD, diabetes, and obesity, progression unfolds across systems, so measurement has to follow it there. Structured architecture keeps that multimodal data consistent and comparable from protocol initiation through database lock.

Inside the Cardiovascular Measurement Overview

  • The four-part, measurement-first framework, from mechanistic alignment through longitudinal and event modeling
  • The five measurement domains covered, spanning cardiac physiology, functional mobility, imaging, biomarkers, and PROs
  • How the models extend into cardiometabolic context, including heart failure, CKD, diabetes, obesity, and rare cardiomyopathies

Download the overview, or schedule a scientific consultation to explore your cardiovascular measurement strategy with Koneksa.

Download the fact sheet

Click here to access the full resource.

Related Resources

Giving Voice to Early Parkinson’s DetectionCase Study

Giving Voice to Early Parkinson’s Detection

koneksa_podcast_cover_image
Human-in-the-Loop: Why Experts Matter More in the Age of AIPodcast

Human-in-the-Loop: Why Experts Matter More in the Age of AI

Lodestar Webinar thumnbail
Meet Lodestarâ„¢: Your North Star for Regulatory SubmissionsWebinar

Meet Lodestarâ„¢: Your North Star for Regulatory Submissions